amitriptyline has been researched along with Kahler Disease in 5 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our previous study indicated that the antidepressant amitriptyline showed potent activity in inducing multiple myeloma (MM) cell apoptosis in vitro." | 7.79 | The antidepressant amitriptyline shows potent therapeutic activity against multiple myeloma. ( Cao, B; Du, X; Mao, X; Zhang, Z; Zhao, C; Zhao, Y, 2013) |
| "Our previous study indicated that the antidepressant amitriptyline showed potent activity in inducing multiple myeloma (MM) cell apoptosis in vitro." | 3.79 | The antidepressant amitriptyline shows potent therapeutic activity against multiple myeloma. ( Cao, B; Du, X; Mao, X; Zhang, Z; Zhao, C; Zhao, Y, 2013) |
| "Amitriptyline is a classic tricyclic antidepressant (TCA) and has been used to treat the depression and anxiety of patients with cancer, but its relevance to cancer cell apoptosis is not known." | 1.37 | The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidence. ( Cao, B; Chen, S; Fei, M; Gronda, M; Hou, T; Hurren, R; Li, Z; Mao, X; Schimmer, AD; Trudel, S; Wang, W; Wu, D, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Z | 1 |
| Du, X | 1 |
| Zhao, C | 1 |
| Cao, B | 2 |
| Zhao, Y | 1 |
| Mao, X | 2 |
| Azadeh, N | 1 |
| Kelemen, K | 1 |
| Fonseca, R | 1 |
| Hou, T | 1 |
| Wang, W | 1 |
| Li, Z | 1 |
| Chen, S | 1 |
| Fei, M | 1 |
| Hurren, R | 1 |
| Gronda, M | 1 |
| Wu, D | 1 |
| Trudel, S | 1 |
| Schimmer, AD | 1 |
| Tilz, GP | 1 |
| Teubl, I | 1 |
| Kopplhuber, C | 1 |
| Vollmann, H | 1 |
| Lanzer, G | 1 |
| Kilpatrick, R | 1 |
| Smith, AJ | 1 |
1 review available for amitriptyline and Kahler Disease
| Article | Year |
|---|---|
Advances in medicine.
Topics: Amitriptyline; Cholera; Coronary Disease; Crohn Disease; Diabetes Mellitus; Diet Therapy; Diverticul | 1971 |
4 other studies available for amitriptyline and Kahler Disease
| Article | Year |
|---|---|
The antidepressant amitriptyline shows potent therapeutic activity against multiple myeloma.
Topics: Administration, Oral; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Antineoplastic Agent | 2013 |
Amitriptyline-induced agranulocytosis with bone marrow confirmation.
Topics: Agranulocytosis; Amitriptyline; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocol | 2014 |
The tricyclic antidepressant amitriptyline inhibits D-cyclin transactivation and induces myeloma cell apoptosis by inhibiting histone deacetylases: in vitro and in silico evidence.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survi | 2011 |
[Therapeutic plasmapheresis--a new form of adjuvant treatment (author's transl)].
Topics: Adult; Amitriptyline; Antilymphocyte Serum; Bone Neoplasms; Female; Hemophilia A; Humans; Hyperthyro | 1976 |